$63.1 MillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
-Net income is all revenues minus all expenses including taxes and interest in the last quarter.
$-2.32Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-4.16xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
-Earnings before interest expenses and taxes in the last quarter.
6The number of full time employees.
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded in April 2007 and is headquartered in San Diego, CA.
Organovo Holdings, Inc. (NASDAQ:ONVO) shares traded up 29.9% during mid-day trading on Wednesday . The stock traded as high as $11.39 and last traded at $10.81. 1,321,382 shares changed hands durin...The Olympia Report, about 23 hours ago
Global 3d Bioprinting Market Size By Component (Micro Extrusion, Inkjet, Laser), By Material (Hydrogel, Living Cells), By Application (Skin, Drug Research), End-User (Biopharma, Academia), Region (...OpenPR, 22 days ago
The 3D Printing ETF (CBOE: PRNT), the lone ETF focusing on the 3D printing theme, jumped nearly 5% last week and is closing in on new highs. Importantly, there were multiple fundamental reasons for...ETF Trends, about 2 months ago